Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Small Cell Carcinoma. Found 10 abstracts

Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE. Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance). Journal of Clinical Oncology. 2017 Jul;35(19):2184-92.   PMCID: PMC5493050
Langer CJ. Irinotecan in advanced lung cancer: focus on North American trials. Oncology (Huntington). 2004 Jun;18(7 Suppl 4):17-28.
Kaminski JM, Anderson PR, Han AC, Mitra RK, Rosenblum NG, Edelson MI. Primary small cell carcinoma of the vagina. Gynecol Oncol. 2003 Mar;88(3):451-5.
Kreamer KM. Getting the lowdown on lung cancer. Nursing. 2003 Nov;33(11):36-42; quiz 42-3.
Treat J. Weekly topotecan in the management of lung cancer. Lung Cancer. 2003 Aug;41 Suppl 4:S27-31.
Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene. 2002 Oct 07;21(45):6877-83.
Chin R, McCain TW, Miller AA, Dunagan DP, Acostamadiedo J, Douglas Case L, Harkness BA, Adler LP, Haponik EF. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. Lung Cancer. 2002 Jul;37(1):1-6.
Huang CH, Treat J. New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors. Oncology. 2001 Jan;61 Suppl 1:14-24.
Chen SH, Qian M, Brennan JM, Gallo JM. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis. J Chromatogr B Biomed Sci Appl. 1997 Apr 25;692(1):43-51.
Testa JR, Liu Z, Feder M, Bell DW, Balsara B, Cheng JQ, Taguchi T. Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet. 1997 May;95(1):20-32.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Small Cell Carcinoma

Small Cell Carcinoma Lung Neoplasms Human Non-Small-Cell Lung Carcinoma Antineoplastic Combined Chemotherapy Protocols Female Non-US Gov't Support drug therapy pathology genetics administration & dosage therapy Neoplasm Staging US Gov't Support-PHS Antineoplastic Agents Survival Rate Middle Aged Male Comparative Study Enzyme Inhibitors diagnosis Type I DNA Topoisomerases Topotecan Adjuvant Radiotherapy Karyotyping therapeutic use enzymology Prognosis Clinical Trials Magnetic Resonance Imaging Emission-Computed Tomography ai [Antagonists & Inhibitors] Taxoids Dinoprostone 951-77-9 (Deoxycytidine) High Pressure Liquid Chromatography Nude Mice 53643-48-4 (Vindesine) Drug Administration Schedule Vaginal Neoplasms Celecoxib etiology Prospective Studies Treatment Outcome biosynthesis Antisense Oligonucleotides drug effects dt [Drug Therapy] analysis Animal EC 1-17-4 (Ribonucleotide Reductases) Patient Care Planning Double-Blind Method Capillary Electrophoresis 103882-84-4 (gemcitabine) tu [Therapeutic adverse effects Ion Exchange Chromatography Antineoplastic Antimetabolites ad [Administration & Dosage] Fludeoxyglucose F 18 Phytogenic Antineoplastic Agents 7689-03-4 (Camptothecin) North America Ribonucleotide Reductases Pemetrexed Phytogenic) 0 (Antineoplastic Agents Cyclooxygenase 2 Inhibitors Nucleic Acid Hybridization Tumor Suppressor Genes X-Ray Computed Tomography Case Report metabolism 0 (Antineoplastic Combined Chemotherapy Protocols) Carboplatin Adjuvant Chemotherapy Thionucleotides urine 0 (Taxoids) Cyclooxygenase 2 Radiation Pneumonitis nursing drug Gene Amplification Reproducibility of Results Survival Analysis 33419-42-0 (Etoposide) Camptothecin Chromosome Aberrations chemistry Antineoplastic) 0 (Antimetabolites Cisplatin Disease-Free Survival diagnostic use radionuclide imaging aa [Analogs & Derivatives] Aged 0 (Antineoplastic Agents) Site-Specific DNA Methyltransferase (Cytosine-Specific) Esophagitis Etoposide 15663-27-1 (Cisplatin) Deoxycytidine 100286-90-6 (irinotecan) Vindesine 0 (Enzyme Inhibitors) mortality Use] Mice Tissue Distribution Radiopharmaceuticals tu [Therapeutic Use] Smoking Gene Deletion Type I) EC 5-99-1-2 (DNA Topoisomerases Human Chromosomes Anecdotes
Last updated on Monday, August 10, 2020